Yes...it is old news,... but, gives some insight as to the chronological order of R&D spending starting with Progenics as far back as 2003...with $21,255,761.00 up until 2010...when Drexel University picked up the baton with a budget of $ 8,306,860.00...petering down to $63,220.00 in year 2019...when Jonah B. Sacha of Oregon Health and Services spent $2,270,727.00 in years 2019 and 2020...
The total amount of money spent on R&D for Pro140/HIV therapy turns out to be $34,104,075.00... a princely sum for ONE indication.